This inventor holds 1 USPTO granted patent. Top assignee: Texas Tech University System. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Sathish Sivaprakasam and Metabolic Health Innovation.
Introduction
Sathish Sivaprakasam is an inventor associated with Texas Tech University System in Lubbock, Texas. His patent work focuses on a potential oral treatment for metabolic conditions, including diabetes and obesity.
Latest Patents
Sivaprakasam is credited with 1 patent: “Alpha-methyl-L-tryptophan as an orally active drug for treating or preventing metabolic conditions.” The patent describes methods and compositions using alpha-methyl-L-tryptophan to treat or prevent conditions such as hyperglycemia, diet-induced diabetes, insulin resistance, metabolic syndrome, excess weight, obesity, and hepatic steatosis. Some embodiments also include instructions for administering the composition.
Career Highlights
His disclosed invention applies alpha-methyl-L-tryptophan in an orally administered composition intended to address a range of metabolic health conditions. The work reflects research into potential therapeutic approaches to metabolic disorders.
Collaborations
Sivaprakasam’s listed coworkers include Vadivel Ganapathy and Yangzom D. Bhutia. His institutional affiliation is the Texas Tech University System.
Conclusion
Sathish Sivaprakasam’s patent centers on the potential use of alpha-methyl-L-tryptophan to treat or prevent several metabolic conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile